20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Kodiak Sciences Inc (KOD) operates in the BIOTECHNOLOGY industry and is headquartered in Palo Alto, United States with about 141 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, KOD reported $0M in revenue and ($230M) in net income.
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.
Interactive charts & full statements →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | — | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Gross Profit | — | — | ($27M) | ($26M) | ($11M) | ($9M) | ($4M) | ($1M) | $0M | ($1M) | $0M |
| Gross Margin % | — | — | — | — | — | — | — | — | — | — | — |
| Operating Income (EBIT) | ($246M) | ($234M) | ($187M) | ($277M) | ($341M) | ($267M) | ($136M) | ($49M) | ($26M) | ($26M) | ($17M) |
| Operating Margin % | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | ($242M) | ($230M) | ($176M) | ($260M) | ($334M) | ($267M) | ($133M) | ($47M) | ($41M) | ($28M) | ($17M) |
| Net Margin % | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | ($220M) | ($204M) | ($150M) | ($235M) | ($323M) | ($258M) | ($129M) | ($46M) | ($35M) | ($26M) | ($17M) |
| Earnings Per Share (EPS) | $-4.22 | $-4.32 | $-3.35 | $-4.97 | $-6.39 | $-5.16 | $-2.91 | $-1.25 | $-1.16 | $-1.05 | $-2.30 |
| Shares Outstanding (M) | 63M | 53M | 53M | 52M | 52M | 52M | 46M | 38M | 36M | 27M | 7M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | — | $0M | $0M | $0M | $0M | $0M | $27M | $0M |
| Gross Profit | — | ($6M) | $20M | ($7M) | ($7M) | ($7M) | ($7M) | ($7M) |
| Gross Margin % | — | — | — | — | — | — | -25.1% | — |
| Operating Income (EBIT) | ($67M) | ($60M) | ($57M) | ($62M) | ($56M) | ($59M) | ($46M) | ($47M) |
| Operating Margin % | — | — | — | — | — | — | -173.2% | — |
| Net Income | ($66M) | ($58M) | ($57M) | ($61M) | ($54M) | ($57M) | ($44M) | ($44M) |
| Net Margin % | — | — | — | — | — | — | -165.5% | — |
| EBITDA | ($67M) | ($52M) | ($47M) | ($55M) | ($48M) | ($51M) | ($37M) | ($37M) |
| Earnings Per Share (EPS) | $-1.05 | $-0.94 | $-1.07 | $-1.16 | $-1.03 | $-1.09 | $-0.84 | $-0.84 |
| Shares Outstanding (M) | 63M | 62M | 53M | 53M | 53M | 53M | 53M | 53M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($159M) | ($136M) | ($117M) | ($154M) | ($206M) | ($182M) | ($83M) | ($39M) | ($29M) | ($18M) | ($16M) |
| Capital Expenditures (CapEx) | $1M | $1M | $0M | $41M | $47M | $63M | $7M | $0M | $1M | $0M | $1M |
| Free Cash Flow (FCF) | ($160M) | ($137M) | ($118M) | ($196M) | ($254M) | ($246M) | ($90M) | ($40M) | ($30M) | ($18M) | ($17M) |
| FCF Margin % | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | $8M | $10M | $6M | $2M | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($46M) | ($40M) | ($39M) | ($33M) | ($35M) | ($29M) | ($30M) | ($21M) |
| Capital Expenditures (CapEx) | $0M | $1M | $0M | $0M | $0M | $0M | $0M | $0M |
| Free Cash Flow (FCF) | ($47M) | ($41M) | ($39M) | ($33M) | ($35M) | ($29M) | ($30M) | ($21M) |
| FCF Margin % | — | — | — | — | — | — | -113.3% | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $257M | $352M | $336M | $479M | $667M | $904M | $1.1B | $359M | $92M | $3M | $12M |
| Cash & Cash Equivalents | $126M | $210M | $168M | $286M | $190M | $732M | $944M | $212M | $88M | $1M | $10M |
| Total Liabilities | $196M | $194M | $185M | $214M | $230M | $241M | $207M | $14M | $5M | $72M | $53M |
| Total Debt (Short + Long-Term) | $10M | $12M | $11M | $10M | $10M | $4M | $2M | $0M | $0M | $10M | $0M |
| Total Shareholders' Equity | $61M | $157M | $150M | $266M | $436M | $663M | $861M | $345M | $87M | ($69M) | ($41M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive KOD viewer.
About TickerBase · Data methodology & sources · Privacy · Terms